← Leaderboards
Daniel A. Grande
Tissue Genesis, Inc.
$323,824
Attributed
$323,824
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $223.8K · FY2010–14$250K$187.5K$125K$62.5K$0
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$323,824 · 3
By mechanism
R41$322,129 · 2
M01$1,695 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingHip Region StructureCollagenArticular CartilageAmericanAnalogAdverse EffectsAreaAggrecanArthropathiesArthroplastyAnti-Inflammatory AgentsAttenuatedBiologicalBiotechnologyBiomechanicsBoneBone Morphogenetic ProteinsCanis FamiliarisCartilageCartilage MatrixCategoriesCeramicsAnti-Inflammatory
Grant awards (3)
Evaluation of TRB-N0224, a Proprietary Chemically-Modified Curumin, for the Treat$223,797
R41 · FY2014 · AG · contact PI
INVESTIGATION OF METAL ION CONCENTRATION FOLLOWING TOTAL HIP ARTHROPLASTY$1,695
M01 · FY2010 · RR · contact PI
Combined Gene Therapy/Tissue Engineered Cartilage Repair$98,332
R41 · FY2001 · AR